App aims to improve life for brain tumor patients
NCT ID NCT07439302
First seen Mar 02, 2026 · Last updated Jun 16, 2026 · Updated 15 times
Summary
This study tests a smartphone app called Resilience PRO to help monitor symptoms and quality of life in 80 adults with IDH-mutated glioma, a type of brain tumor. Participants will use the app to report how they feel every two weeks while starting a new cancer treatment. The goal is to see if the app helps doctors better manage side effects and improve daily living.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ONCOLOGY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Service de Neuro-oncologie, Hôpital de la Pitié-Salpêtrière
Paris, 75013, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.